Try our mobile app

General information

Country: UNITED STATES

Sector: Utilities — Regulated Electric

CenterPoint Energy, Inc. is a public utility holding company. The Company, through its subsidiaries, conducts activities in electricity transmission and distribution, natural gas distribution, interstate pipeline and gathering operations, and power generation.
  • Dividend yield for the last twelve months 2.3%
  • Free cash flow yield -7.9% (LTM)
  • Share price is 49.4% higher than minimum and 4.8% lower than maximum for the last 3 years
  • The company is overvalued by EV / LTM EBITDA multiple compared to target level (13.4x vs
    )
  • For the last 3 months insiders sold company shares on $0.2 mln (-0.001% of cap.)

Key Financials (Download financials)

Ticker: CNP
Share price, USD:  (-2.6%)38.29
year average price 37.15  


year start price 32.56 2025-01-18

min close price 32.15 2025-02-04

max close price 40.22 2025-10-20

current price 38.29 2026-01-18
Common stocks: 629 449 030

Dividend Yield:  2.3%
FCF Yield LTM: -7.9%
EV / LTM EBITDA: 13.4x
EV / EBITDA annualized: 14.2x
Target EV / EBITDA (hist percentile):
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 24 102
Net Debt ($m): 19 765
EV (Enterprise Value): 43 867
EBITDA LTM ($m): 3 278
EV / LTM EBITDA: 13.4x
Price to Book: 2.3x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / LTM EBITDA and 75% percentile

Potential dynamics

News


2025-12-29zacks.com

CNP to Benefit From Infrastructure Upgradation & Renewable Expansion

2025-12-17zacks.com

4 Stocks That Declared Dividend Hikes Amid Ongoing Economic Uncertainty

2025-12-17zacks.com

5 Stocks Worth Watching on Their Recent Dividend Hikes

2025-12-15seekingalpha.com

Here's My Prediction For Who Could Acquire Ascendis Pharma

2025-12-11businesswire.com

CenterPoint Energy Declares Regular Common Stock Dividend of $0.2300

2025-12-03seekingalpha.com

CenterPoint Energy: A Particularly Well-Positioned Utility

2025-11-25globenewswire.com

Ascendis Announces Extension of FDA Review Period for TransCon CNP (navepegritide) for Children with Achondroplasia

2025-11-21zacks.com

CenterPoint (CNP) Upgraded to Buy: Here's Why

2025-11-18zacks.com

Here's Why CNP Stock Deserves a Place in Your Portfolio Right Now

2025-10-23zacks.com

CenterPoint Energy Q3 Earnings Beat Estimates, Revenues Improve Y/Y
More information for subscribed users:
detailed calculation of Potential,
commodities and currency affecting the company